We like to invest early, when founding teams are coalescing and real relationships start. We lead a lot of our deals to help ensure a strong start. Holding onto your vision while navigating the day to day is hard, really hard. Our experience and founder-focus can help.

Science is beginning to act more like technology. As it becomes programmable and predictable, it becomes more investible.  AI applied to biological and chemical data is compressing timelines and collapsing cost curves. What was once a lottery ticket is becoming a repeatable, scalable asset class.

A decade in, our conviction in founders unlocking the power of science with technology has only sharpened. Building at this frontier requires conviction, deep technical understanding, and the ability to see around corners, something we are known for.